Chief Executive Officer, LevitasBio
Biography
Mr. Pieprzyk is a highly technical life science executive who brings deep knowledge of the Life Science Industry, with extensive experience in single-cell genomics, next-generation sequencing, gene expression, microfluidics, and digital PCR applications. He is also well versed in company development and funding, from inception through IPO process and public company operations.
Clinical & Research Tools Showcase:
LevitasBio
LevitasBio is advancing science and human health by providing researchers with a new and powerful tool for cellular processing and characterization. Our disruptive levitation technology overcomes current technological limitations by providing a gentle, label-free method of purifying, enriching and characterizing specific cell populations.
Empowering the Next Generation of Cellular Analysis
Founded on proprietary label-free levitation technology, LevitasBio has delivered the first truly novel approach to cellular analysis in 30 years.
Researchers can now isolate and rescue high quality cells of interest while ensuring the integrity of downstream data and analysis is maintained.
Session Abstract – PMWC 2022 Silicon Valley
Track 6 - June 28 4.00 P.M.-4.15 P.M.,Track 6 - June 29 9.00 A.M.-1.15 P.M.,Track 6 - June 30 1.45 P.M.-2.00 P.M.
The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
